載入...

Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019

BACKGROUND: Digoxin immune fab products, DigiBind and DigiFab, are antidotes for the treatment of patients with life-threatening or potentially life-threatening digoxin toxicity or overdose. Although approved by the US Food and Drug Administration (FDA) in 1986 (DigiBind) and 2001 (DigiFab), there r...

全面介紹

Na minha lista:
書目詳細資料
發表在:Drugs Real World Outcomes
Main Authors: Wei, Shaokui, Niu, Manette T., Dores, Graça M.
格式: Artigo
語言:Inglês
出版: Springer International Publishing 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8128941/
https://ncbi.nlm.nih.gov/pubmed/33721285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-021-00242-x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!